United Kingdom
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 37.77 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
2 |
USD 27.69 B
|
Dec. 31, 2023 | USD 15.79 | -2.73% |
|
United Kingdom |
|
3 |
USD 11.15 B
|
Dec. 31, 2023 | USD 59.37 | -0.51% |
|
United Kingdom |
|
4 |
USD 8.58 B
|
Dec. 31, 2023 | USD 4.48 | -0.21% |
|
United Kingdom |
|
5 |
USD 7.56 B
|
Dec. 31, 2023 | USD 45.94 | 0.03% |
|
United Kingdom |
|
6 |
USD 3.89 B
|
Dec. 31, 2023 | USD 11.94 | -0.50% |
|
United Kingdom |
|
7 |
USD 1.72 B
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
8 |
USD 1.41 B
|
Dec. 31, 2023 | USD 24.44 | -0.21% |
|
United Kingdom |
|
9 |
USD 1.27 B
|
March 31, 2024 | USD 32.51 | 0.69% |
|
United Kingdom |
|
10 |
USD 1.20 B
|
Dec. 31, 2023 | USD 2.80 | 1.24% |
|
United Kingdom |
|
11 |
USD 771.25 M
|
Dec. 31, 2023 | USD 47.63 | 0.66% |
|
United Kingdom |
|
12 |
USD 351.74 M
|
June 30, 2024 | USD 9.99 | -0.88% |
|
United Kingdom |
|
13 |
USD 248.39 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
14 |
USD 133.62 M
|
Dec. 31, 2023 | USD 0.75 | -0.07% |
|
United Kingdom |
|
15 |
USD 109.23 M
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
16 |
USD 105.80 M
|
Sept. 30, 2024 | USD 18.48 | 0.49% |
|
United Kingdom |
|
17 |
USD 89.24 M
|
Dec. 31, 2023 | USD 2.66 | 14.48% |
|
United Kingdom |
|
18 |
USD 59.49 M
|
Sept. 30, 2024 | USD 5.40 | -1.25% |
|
United Kingdom |
|
19 |
USD 50.55 M
|
Dec. 31, 2023 | USD 4.79 | -4.31% |
|
United Kingdom |
|
20 |
USD 47.55 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
21 |
USD 45.35 M
|
Dec. 31, 2023 | USD 2.92 | -0.33% |
|
United Kingdom |
|
22 |
USD 41.52 M
|
Dec. 31, 2023 | USD 0.78 | 0.09% |
|
United Kingdom |
|
23 |
USD 40.21 M
|
Dec. 31, 2023 | USD 6.20 | -2.97% |
|
United Kingdom |
|
24 |
USD 39.07 M
|
June 30, 2024 | USD 4.76 | -2.41% |
|
United Kingdom |
|
25 |
USD 37.64 M
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
|
26 |
USD 34.14 M
|
Dec. 31, 2023 | USD 0.32 | 0.09% |
|
United Kingdom |
|
27 |
USD 33.72 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
28 |
USD 30.36 M
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
29 |
USD 25.64 M
|
Dec. 31, 2023 | USD 0.46 | 0.09% |
|
United Kingdom |
|
30 |
USD 22.69 M
|
Jan. 31, 2024 | USD 0.16 | 0.87% |
|
United Kingdom |
|
31 |
USD 21.71 M
|
March 31, 2024 | USD 2.90 | -3.96% |
|
United Kingdom |
|
32 |
USD 20.51 M
|
Dec. 31, 2023 | USD 14.81 | -2.31% |
|
United Kingdom |
|
33 |
USD 20.49 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
34 |
USD 19.16 M
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
35 |
USD 15.91 M
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
36 |
USD 14.31 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
37 |
USD 14.04 M
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
38 |
USD 13.74 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
39 |
USD 13.25 M
|
Dec. 31, 2023 | USD 0.21 | 6.16% |
|
United Kingdom |
|
40 |
USD 8.57 M
|
July 31, 2024 | USD 0.16 | -0.69% |
|
United Kingdom |
|
41 |
USD 7.43 M
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
42 |
USD 6.85 M
|
Dec. 31, 2023 | USD 14.84 | -2.75% |
|
United Kingdom |
|
43 |
USD 5.82 M
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
44 |
USD 5.12 M
|
Dec. 31, 2023 | USD 0.03 | -0.76% |
|
United Kingdom |
|
45 |
USD 4.66 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
46 |
USD 3.68 M
|
June 30, 2024 | USD 1.47 | -0.73% |
|
United Kingdom |
|
47 |
USD 3.63 M
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
48 |
USD 2.26 M
|
Dec. 31, 2023 | USD 0.37 | -1.16% |
|
United Kingdom |
|
49 |
USD 2.17 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
50 |
USD 2.10 M
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
The Pharmaceuticals company in United Kingdom with the highest Gross Profit is AstraZeneca PLC (LSE: AZN.L) at USD 37.77 B.
The Pharmaceuticals company in United Kingdom with the lowest Gross Profit is Autolus Therapeutics plc (NasdaqGS: AUTL) at USD -4.87 M.
The top 10 Pharmaceuticals companies in United Kingdom by Gross Profit are AstraZeneca PLC, GSK plc, Reckitt Benckiser Group plc, Haleon plc, RELX PLC, Smith & Nephew plc, Clarivate Plc, Hikma Pharmaceuticals PLC, Halma plc and ConvaTec Group Plc.
The bottom 10 Pharmaceuticals companies in United Kingdom by Gross Profit are Autolus Therapeutics plc, Biodexa Pharmaceuticals Plc, Scancell Holdings plc, Hemogenyx Pharmaceuticals Plc, Verona Pharma plc, ANGLE plc, Fusion Antibodies plc, COMPASS Pathways plc, Synairgen plc and ImmuPharma plc.